13 trends tracked about this subject — the full history, oldest to newest below.
Novartis and Bristol Myers Squibb halt autoimmune CAR-T trials following patient deaths, impacting the sector.
New medical guidance identifies seven additional risk factors for dementia, highlighting a significant gap in public awareness among adults over 40.
Novartis and Bristol Myers Squibb halt multiple CAR-T clinical trials for autoimmune diseases following patient deaths and safety reviews.
6 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
The FDA has granted accelerated approval to Bristol Myers Squibb's Zenbexus, introducing a novel CELMoD drug class for multiple myeloma treatment.
5 news sources are covering this Sports story right now — PULSE is tracking how fast it spreads.
4 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
Taxpayers have spent nearly £150,000 on the clean-up and security of three Banksy artworks located in London.
Bristol Motor Speedway is among the tracks confirming 2027 NASCAR dates as scheduling announcements unfold across multiple outlets.
4 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
5 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
Bristol Myers Squibb is partnering with Nvidia to construct what it claims will be the most powerful AI supercomputer in the pharmaceutical industry.
5 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.